The present invention relates to an in vitro method of diagnosing a neurological disease associated with at least one symptom selected from the group comprising non-motor symptoms, sleep-wake disorders, sensory disorders, neuropsychiatric disorders and cognitive difficulties, comprising measuring the amount of active c-Rel factor in a biological sample comprising endogenous c-Rel factor from a patient.
AN IN VITRO METHOD OF DIAGNOSING PARKINSON'S DISEASE